pentetic acid has been researched along with Heart Disease, Ischemic in 14 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simor, T | 3 |
| Gaszner, B | 1 |
| Oshinski, JN | 1 |
| Waldrop, SM | 1 |
| Pettigrew, RI | 1 |
| Horváth, IG | 1 |
| Hild, G | 1 |
| Elgavish, GA | 3 |
| Ruzsics, B | 1 |
| Surányi, P | 1 |
| Kiss, P | 1 |
| Brott, BC | 1 |
| Elgavish, A | 1 |
| Saab-Ismail, NH | 1 |
| Nilsson, S | 1 |
| Chandra, M | 1 |
| Machnig, T | 1 |
| Koroneos, A | 1 |
| Engels, G | 1 |
| Bachmann, K | 1 |
| Simm, C | 1 |
| Wilke, N | 1 |
| Ellermann, J | 1 |
| Zhang, J | 1 |
| Ya, X | 1 |
| Merkel, H | 1 |
| Arteaga, C | 1 |
| Canet, E | 1 |
| Ovize, M | 1 |
| Janier, M | 1 |
| Revel, D | 1 |
| Tong, CY | 2 |
| Prato, FS | 2 |
| Wisenberg, G | 2 |
| Lee, TY | 2 |
| Carroll, E | 2 |
| Sandler, D | 2 |
| Wills, J | 2 |
| Drost, D | 1 |
| Wendland, MF | 2 |
| Saeed, M | 3 |
| Masui, T | 1 |
| Derugin, N | 2 |
| Moseley, ME | 1 |
| Higgins, CB | 3 |
| Chu, WJ | 1 |
| Johnson, L | 1 |
| Safranko, A | 1 |
| Doyle, M | 1 |
| Pohost, GM | 1 |
| Kim, RJ | 1 |
| Chen, EL | 1 |
| Lima, JA | 1 |
| Judd, RM | 1 |
| Szolar, DH | 1 |
| Wendland, M | 1 |
| Sakuma, H | 1 |
| Stiskal, MA | 1 |
| Beache, GM | 1 |
| Kulke, SF | 1 |
| Kantor, HL | 1 |
| Niemi, P | 1 |
| Campbell, TA | 1 |
| Chesler, DA | 1 |
| Gewirtz, H | 1 |
| Rosen, BR | 1 |
| Brady, TJ | 1 |
| Weisskoff, RM | 1 |
| Lund, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study[NCT02563964] | 10 participants (Actual) | Observational [Patient Registry] | 2017-09-01 | Terminated (stopped due to Logistical reasons and slow recruitment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pentetic acid and Heart Disease, Ischemic
| Article | Year |
|---|---|
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imagin | 1999 |
13 other studies available for pentetic acid and Heart Disease, Ischemic
| Article | Year |
|---|---|
Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart.
Topics: Analysis of Variance; Animals; Contrast Media; Dogs; Image Processing, Computer-Assisted; Magnetic R | 2005 |
Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs.
Topics: Alanine Transaminase; Amylases; Anesthetics, Inhalation; Animals; Blood Proteins; Contrast Media; Do | 2006 |
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studi | 1995 |
Metabolic complexities in cardiac imaging.
Topics: Contrast Media; Echo-Planar Imaging; Gadolinium DTPA; Heart; Humans; Magnetic Resonance Spectroscopy | 1995 |
[Quantitative evaluation of myocardial perfusion with ultrafast magnetic resonance tomography].
Topics: Adult; Aged; Animals; Blood Flow Velocity; Contrast Media; Coronary Circulation; Dipyridamole; Dogs; | 1994 |
Myocardial perfusion assessed by subsecond magnetic resonance imaging with a paramagnetic macromolecular contrast agent.
Topics: Animals; Coronary Circulation; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Ischemia; Org | 1994 |
Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Gadolinium; Gadolinium DTPA; In Vitro Technique | 1993 |
Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Female; Gadolinium; Gadolinium DTPA; Magnetic R | 1993 |
Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection.
Topics: Animals; Echo-Planar Imaging; Female; Gadolinium DTPA; Heart; Myocardial Ischemia; Organometallic Co | 1993 |
In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA).
Topics: Animals; Contrast Media; Electrocardiography; Ferrets; Gadolinium DTPA; Magnetic Resonance Imaging; | 1995 |
Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction.
Topics: Analysis of Variance; Animals; Edema; Gadolinium; Gadolinium DTPA; Hemorrhage; Magnetic Resonance Im | 1996 |
Quantification of area at risk during coronary occlusion and reperfusion by means of MR perfusion imaging.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Feasibility Studies; Gadolinium; Gadolinium DTP | 1997 |
Imaging perfusion deficits in ischemic heart disease with susceptibility-enhanced T2-weighted MRI: preliminary human studies.
Topics: Adult; Aged; Artifacts; Contrast Media; Dysprosium; Feasibility Studies; Female; Humans; Image Enhan | 1998 |